A tool for comprehensive analysis of the literature to support the development of Adverse Outcome Pathways (AOPs).
Self Assessment Questionnaire (SAQ) for in vitro test method
In ordrer to be adopted as Test Guidelines by the OECD (preliminary step before a method is required for regulatory testing), each in vitro test method developed to identify endocrine disruptors (ED) needs to be validated. To speed up this process that is time- and cost-consuming, we propose with this plateform a Self Assessment Questionnaire (SAQ) to assess the readlines of the method you are developing. This SAQ is intended for in vitro method only.